Incarceration and HIV-Infected Inmates
Incarceration and HIV-Infected Inmates
批准号:
7338067
负责人:
DAVID A WOHL
金额:
$47.14万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-19 至 2011-07-31
关键词:
AIDS preventionAIDS/HIV problemAcuteAfrican AmericanAppendixAreaAttentionBloodCaringCharacteristicsChronicConfidentialityConsentCounselingDataDecision MakingDevice or Instrument DevelopmentDiagnosisEffectivenessEnrollmentEpidemicFigs - dietaryFrightGoalsHIVHIV AntibodiesHIV InfectionsHIV diagnosisHigh PrevalenceHighly Active Antiretroviral TherapyHuman immunodeficiency virus testImprisonmentIndividualInfectionInformation SystemsInterventionInvestigationJailLifeLiteratureMeasurementMeasuresMediator of activation proteinModelingNorth CarolinaNursesOpportunistic InfectionsPatient Outcomes AssessmentsPersonsPoliciesPopulationPredispositionPrevalencePreventionPrisonerPrisonsPrivacyProceduresProcessProfessional counselorProphylactic treatmentPublic HealthPunishmentQuestionnairesRaceRateResearchResearch PersonnelRiskRisk BehaviorsRoleRole playing therapySamplingSecuritySelf EfficacySeveritiesSiteSyphilis SerodiagnosisSystemTest ResultTestingTheoretical modelThinkingTraumaTrustUnited States Dept. of Health and Human ServicesViralantiretroviral therapydesignimprovedinstrumentinterestmedical schoolsphysical abuseprogramstherapy designtransmission processuptakevolunteer
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Nearly 20% of all people infected with HIV in the US pass through a correctional facility each year. Several studies suggest that the prevalence of HIV infection among prisoners is between 8 and 10-fold higher than the prevalence in non-incarcerated populations and a significant proportion of inmates are at elevated risk for infection. Voluntary counseling and testing (VCT) of individuals at risk for HIV infection is an effective means of primary and secondary HIV prevention. The North Carolina Department of Corrections (NCDOC) has a voluntary HIV testing policy and 70% of all incoming inmates decline the opportunity to receive testing. As is the case for the other 31 state prison systems that employ voluntary testing, this is a lost opportunity to identify infected people and enroll them in care. Unfortunately, we are missing several pieces of information required both to determine the true prevalence of HIV infection among incarcerated people as well as to understand how newly incarcerated people make the decision to receive an HIV test. In a collaborative effort between researchers at the UNC Schools of Medicine and Public Health and officials at the NCDOC and the North Carolina Department of Health and Human Services (NCDHHS), we will perform a comprehensive assessment of the barriers and facilitators of HIV testing in a large state prison system. First, we will determine the actual prevalence of acute and chronic HIV infection among incoming inmates and characterize the HIV risk behaviors of this group. Second, we will examine the association between the uptake of voluntary HIV testing among recently incarcerated inmates and variables at three levels: individual inmate, NCDOC nurse-counselor and prison processing facility. Finally, we will conduct a preliminary examination of the risks associated with receiving an HIV diagnosis in prison. The ultimate goals of the studies described in this application are to obtain a clearer picture of the impact of HIV infection among this population and to inform the design of interventions to promote HIV VCT in this setting. Specifically, we will: Aim 1. Determine the prevalence of acute and chronic HIV infection in a large state prison system. Aim 2. Determine the inmate, nurse-counselor and facility characteristics associated with agreeing to HIV VCT. Aim 3. Explore the risks associated with receiving an HIV diagnosis in prison.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mentoring New Investigators in Criminal Justice HIV Prevention and Treatment
-
批准号:8731476
-
项目类别:
-
资助金额:$18.28万
-
财政年份:2014
-
负责人:DAVID A WOHL
-
依托单位:
Mentoring New Investigators in Criminal Justice HIV Prevention and Treatment
-
批准号:9084502
-
项目类别:
-
资助金额:$18.24万
-
财政年份:2014
-
负责人:DAVID A WOHL
-
依托单位:
Mentoring New Investigators in Criminal Justice HIV Prevention and Treatment
-
批准号:9472311
-
项目类别:
-
资助金额:$18.16万
-
财政年份:2014
-
负责人:DAVID A WOHL
-
依托单位:
FAT REDISTRIBUTION AND METABOLIC CHANGE IN HIV INFECTION
-
批准号:7716751
-
项目类别:
-
资助金额:$0.85万
-
财政年份:2008
-
负责人:DAVID A WOHL
-
依托单位:
CLINICAL TRIAL: A5235 - MINOCYCLINE IN THE TREATMENT OF HIV-ASSOCIATED COGNITIVE
-
批准号:7716911
-
项目类别:
-
资助金额:$0.3万
-
财政年份:2008
-
负责人:DAVID A WOHL
-
依托单位:
CLINICAL TRIAL: ENFURVITIDE (T-20) INTENSIFICATION FOR LOW LEVEL VIREMIA (THE LO
-
批准号:7716849
-
项目类别:
-
资助金额:$1.46万
-
财政年份:2008
-
负责人:DAVID A WOHL
-
依托单位:
CLINICAL TRIAL: TWO DOSES OF GW433908/RITONAVIR GIVEN WITH ABACAVIR/LAMIVUDINE C
-
批准号:7716816
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2008
-
负责人:DAVID A WOHL
-
依托单位:
LONG-TERM ANTIVIRAL MANAGEMENT OF HCV AND HIV-1 COINFECTED SUBJECTS (SLAM-C)
-
批准号:7716808
-
项目类别:
-
资助金额:$0.73万
-
财政年份:2008
-
负责人:DAVID A WOHL
-
依托单位:
CLINICAL TRIAL: MRK AD5 HIV-1 GAG VACCINE IN HIV-1 SUBJECTS WHO INTERUPT THERAPY
-
批准号:7716792
-
项目类别:
-
资助金额:$1.34万
-
财政年份:2008
-
负责人:DAVID A WOHL
-
依托单位:
CLINICAL TRIAL: PHASE I/II URIDINE SUPPLEMENTATION IN HIV LIPOATROPHY (ACTG A522
-
批准号:7716871
-
项目类别:
-
资助金额:$1.58万
-
财政年份:2008
-
负责人:DAVID A WOHL
-
依托单位:
Incarceration and HIV-Infected Inmates
-
批准号:7679078
-
项目类别:
-
资助金额:$63.58万
-
财政年份:2007
-
负责人:DAVID A WOHL
-
依托单位:
Incarceration and HIV-Infected Inmates
-
批准号:7911756
-
项目类别:
-
资助金额:$29.98万
-
财政年份:2007
-
负责人:DAVID A WOHL
-
依托单位:
EZETIMIBE THERAPY FOR DYSLIPIDEMIA IN PATIENTS RECEIVING HIV THERAPY
-
批准号:7625596
-
项目类别:
-
资助金额:$4.69万
-
财政年份:2006
-
负责人:DAVID A WOHL
-
依托单位:
FAT REDISTRIBUTION AND METABOLIC CHANGE IN HIV INFECTION
-
批准号:7625507
-
项目类别:
-
资助金额:$10.06万
-
财政年份:2006
-
负责人:DAVID A WOHL
-
依托单位:
POTENT COMBINATION OF ANTIRETROVIRAL REGIMEN IN AFRICAN-AMERICAN MEN AND WOMEN
-
批准号:7625535
-
项目类别:
-
资助金额:$1.83万
-
财政年份:2006
-
负责人:DAVID A WOHL
-
依托单位:
TWO DOSES OF GW433908/RITONAVIR GIVEN WITH ABACAVIR/LAMIVUDINE COMBO
-
批准号:7625607
-
项目类别:
-
资助金额:$4.92万
-
财政年份:2006
-
负责人:DAVID A WOHL
-
依托单位:
PHASE II ONCE-WEEKLY ALENDRONATE IN HIV-INFECTED SUBJECTS WITH DECREASED BONE D
-
批准号:7625543
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2006
-
负责人:DAVID A WOHL
-
依托单位:
PHASE I/II URIDINE SUPPLEMENTATION IN HIV LIPOATROPHY (ACTG A5229)
-
批准号:7625670
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2006
-
负责人:DAVID A WOHL
-
依托单位:
PHASE 3 COMPARISON OF LOPINAVIR/RITONAVIR EFAVIRENZ STAVUDINE LAMIVUDINE FOR INI
-
批准号:7625534
-
项目类别:
-
资助金额:$2.75万
-
财政年份:2006
-
负责人:DAVID A WOHL
-
依托单位:
LONG-TERM ANTIVIRAL MANAGEMENT OF HCV AND HIV-1 COINFECTED SUBJECTS (SLAM-C)
-
批准号:7625588
-
项目类别:
-
资助金额:$2.86万
-
财政年份:2006
-
负责人:DAVID A WOHL
-
依托单位: